A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer
Clinical trial NCT00879086 · COMPLETED
Trial details
- NCT number
- NCT00879086
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-31
- Primary completion
- 2013-04-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.